Tiziana Life Sciences Financials - Benzinga

Tiziana Life Sciences Ltd

TLSANASDAQ

Trade with Public

Trade with Public

$1.01

0.011%

At close: Aug 7, 5:00 PM EST

$1.02

0.022%

Pre-Market: 8:04 AM EST

Overview News Earnings Forecast EventsFinancialsSentiment Ownership Compare Options Stock Report

Tiziana Life Sciences Financials

Tiziana Life Sciences (TLSA) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

Why Las Vegas Sands Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Avi Kapoor

Tiziana Life Sciences Ltd Reports Annual Results For The 12 Months Ended December 31, 2022, And Corporate Update; Tiziana Ended The Period With $18.1M Cash

2022 Year End Financial Results For the twelve months ended 31 December 2022 Tiziana reported a loss of $19.0 million compared to $27.9 million in the twelve months ended 31 December

Happy Mohamed

PRO
Tiziana Life Sciences 1H Net Loss $8.3M

Benzinga Newsdesk

PRO
UPDATE: Tiziana Sees Clinical Trial For Crohn's Disease Candidate In Q4'22

Benzinga Newsdesk

The Daily Biotech Pulse: Merck Confirms Acceleron Purchase, Regeneron Touts COVID-19 Antibody Cocktail Data, Takeda In-Licenses Huntington's Disease Drug

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 29)

Shanthi Rexaline

The Daily Biotech Pulse: Assembly Bio Halts HBV Study, Moderna Initiates Submission For COVID-19 Booster Dose, FDA Nod For BeiGene, Tiziana Out-Licenses Foralumab

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 1)

Shanthi Rexaline